Introduction: The distribution of voxel- and connection-based white matter hyperintensity (WMH) patterns in early-onset Alzheimer's disease (EOAD) and late-onset Alzheimer's disease (LOAD), as well as factors associated with these patterns, remain unclear.
Method: We analyzed the WMH distribution patterns in EOAD and LOAD at the voxel and connection levels, each compared with their age-matched cognitively unimpaired participants. Linear regression assessed the independent effects of amyloid and vascular risk factors on WMH distribution patterns in both groups.
Results: EOAD showed increased WMH burden in the posterior region at the voxel level, and in occipital region tracts and visual network at the connection level, compared to controls. LOAD exhibited extensive involvement across various brain areas in both levels. Amyloid accumulation was associated WMH distribution in the early-onset group, whereas the late-onset group demonstrated associations with both amyloid and vascular risk factors.
Discussion: EOAD showed posterior-focused WMH distribution pattern, whereas LOAD was with a wider distribution. Amyloid accumulation was associated with connection-based WMH patterns in both early-onset and late-onset groups, with additional independent effects of vascular risk factors in late-onset group.
Highlights: Both early-onset Alzheimer's disease (EOAD) and late-onset AD (LOAD) showed increased white matter hyperintensity (WMH) volume compared with their age-matched cognitively unimpaired participants.EOAD and LOAD exhibited distinct patterns of WMH distribution, with EOAD showing a posterior-focused pattern and LOAD displaying a wider distribution across both voxel- and connection-based levels.In both EOAD and LOAD, amyloid accumulation was associated with connection-based WMH patterns, with additional independent effects of vascular risk factors observed in LOAD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11033836 | PMC |
| http://dx.doi.org/10.1002/dad2.12585 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
White matter hyperintensities in AD and bvFTD patients from Underrepresented countries.
Alzheimers Dement
December 2024
CONICET, Buenos Aires, Argentina
Background: White matter hyperintensities (WMH) are very common brain MRI signal abnormalities linked to age, small vessel cerebrovascular disease, cognitive impairment, and dementia. Despite extensive research on WMH in Alzheimer's disease (AD), their prevalence in behavioral variant Frontotemporal dementia (bvFTD) remains less explored. Additionally, Latin American countries (LA) exhibit a higher prevalence of cerebrovascular disease due to distinct demographic, socioeconomic, cultural, and ethno‐racial factors.
View Article and Find Full Text PDFWhite matter hyperintensities (WMH) are areas of increased lucency visualized on T2‐weighted magnetic resonance imaging (MRI), including fluid attenuated inversion recovery (FLAIR) sequences. Over the past 15 years we have been examining WMH in studies of cognitive aging among clinical, community‐based, and populations at genetic risk to understand the role of vascular brain injury in Alzheimer’s disease (AD) onset, symptom progression, and pathogenesis. Our findings suggest that regional WMH, particularly when distributed in posterior areas, increase risk for clinical AD and contribute to the clinical course of the disease, even among genetic population with relatively low rates of vascular risk factor, like adults with Down syndrome and with autosomal dominant genetic mutations for AD.
View Article and Find Full Text PDFComparison of MRI T2 FLAIR White Matter Hyperintensity Segmentation Algorithms in Clinical Trials.
Alzheimers Dement
December 2024
Michigan State University, East Lansing, MI, USA
Background: White Matter Hyperintensities (WMH) appear on T2‐weighted Fluid‐Attenuated Inversion Recovery (FLAIR) Magnetic Resonance Imaging (MRI) and are an important biomarker of cerebral small vessel disease (CSVD), cognitive decline, and stroke. However, manual delineation is laborious and bias‐prone, while automated segmentation has proven challenging. With the recent conclusion of the MICCAI‐Society WMH segmentation challenge, and our large clinical trials, “Risk Reduction for Alzheimer’s Disease” (rrAD) and “Hypertension, Intracranial Pulsatility and Brain Amyloid‐beta Clearance in older adults” (HIPAC), we investigated the differences in the total WMH volume segmented by various algorithms to ensure the extraction of accurate and meaningful image‐derived phenotypes.
View Article and Find Full Text PDFA Comparison of DTI‐Based Measures as Predictors of Future Cerebrovascular Degeneration.
Alzheimers Dement
December 2024
Mayo Clinic, Rochester, MN, USA
Background: There has been a recent proliferation of various quantities based on single shell Diffusion Tensor Imaging (DTI) for capturing overall cerebrovascular health, especially Small Vessel Disease (SVD) as a single number. The existing literature has gaps in the comparison of these measures, so we evaluated them as predictors of both current and future White Matter Hyperintensity (WMH) as a proxy of SVD.
Method: Using baseline 3T MRI examinations (T1, DTI, FLAIR scans) of 598 participants (>60 years, amyloid negative, to limit to those on the SVD pathway) from the Mayo Clinic Study of Aging, we calculated five summary DTI quantities with varying degree of complexity.
Longitudinal changes in neuroimaging markers of small vessel disease: Implications for clinical trials.
Alzheimers Dement
December 2024
Department of Neurology, Columbia University, New York, NY, USA
Background: Adults with Down syndrome (DS) overproduce amyloid precursor protein, develop amyloid plaques at an early age, and are diagnosed with Alzheimer’s disease (AD) dementia at a high frequency. There is emerging evidence that cerebrovascular disease is elevated across the AD continuum in older adults with DS, independent of age and vascular risk, around the same time as amyloid and tau, but the regional rates of accumulation within individuals are unknown.
Method: Adults with DS from the multisite Alzheimer’s Biomarker Consortium‐Down Syndrome study (ABC‐DS; n=78; age=50±6; 40% women) have two timepoints of T2 FLAIR MRI (1.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!